or
forgot password

Long-Term Outcomes of Alternative Brachytherapy Techniques for Early Prostate Cancer


N/A
18 Years
N/A
Open (Enrolling)
Male
Prostate Cancer

Thank you

Trial Information

Long-Term Outcomes of Alternative Brachytherapy Techniques for Early Prostate Cancer


Participants will be asked to complete a questionnaire about their health prior to
treatment, at 1, 3 and 12 months after treatment and then once a year 4 more times.


Inclusion Criteria:



- Pathological diagnosis of an adenocarcinoma of the prostate

- 18 years of age or older

- Prior choice of either standard brachytherapy or MRIGPB as primary treatment

Exclusion Criteria:

- Prior primary therapy (surgery or external beam radiation) for prostate cancer

- Current hormone ablation therapy

Type of Study:

Observational

Study Design:

Observational Model: Cohort, Time Perspective: Prospective

Outcome Measure:

To assess changes in generic and disease specific quality of life over time after treatment with brachytherapy for early prostate cancer

Outcome Time Frame:

10 years

Safety Issue:

No

Principal Investigator

James Talcott, MD, SM

Investigator Role:

Principal Investigator

Investigator Affiliation:

Massachusetts General Hospital

Authority:

United States: Institutional Review Board

Study ID:

01-264

NCT ID:

NCT00681694

Start Date:

March 2002

Completion Date:

March 2011

Related Keywords:

  • Prostate Cancer
  • brachytherapy
  • radioactive seed implants
  • Prostatic Neoplasms

Name

Location
Beth Israel Deaconess Medical Center Boston, Massachusetts  02215
Massachusetts General Hospital Boston, Massachusetts  02114-2617
Dana-Farber Cancer Institute/Brigham and Women's Hospital Boston, Massachusetts  02115